Exane Derivatives’s PJT Partners PJT Stock Holding History

Exane Derivatives’s Portfolio PJT Stock Details PJT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	-$35	–	673
2017 Q1	$35	Sell	1 -1,829	-100%	-$63.3K	﹤0.01%	529
2016 Q4	$56.5K	Buy	+1,830	New	+$52.6K	0.01%	290

Other funds holding PJT

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MFM

MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return

Exane Derivatives's PJT Position: Q2 2017 in Review

Exane Derivatives sold out of PJT Partners (PJT) in Q2 2017, closing a stake of 1 share — an estimated $35 sold.

Exane Derivatives first reported a position in PJT in Q4 2016 and held it in 2 quarters. The position peaked at $56.5K in Q4 2016. 191 funds tracked by Wall St. Rank hold PJT as of Q2 2017.

Exane Derivatives reported no remaining PJT Partners position as of Q2 2017 after selling out during the quarter.
Exane Derivatives sold 1 PJT Partners share in Q2 2017, an estimated $35.
Exane Derivatives first reported a position in PJT Partners in Q4 2016 and held it in 2 quarters.
Exane Derivatives's PJT Partners position peaked at $56.5K in Q4 2016.
191 funds tracked by Wall St. Rank held PJT Partners as of Q2 2017.

Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.